Immune‐mediated bone marrow failure syndromes (BMFS) are characterized by ineffective
marrow haemopoiesis and subsequent peripheral cytopenias. Ineffective haemopoiesis is …

Background Many data are available on expansion protocols for mesenchymal stromal cells
(MSCs) for both experimental settings and manufacturing for clinical trials. However, there is …

Considerable advances have been made toward understanding the cellular and molecular
mechanism of wound healing, however, treatments for chronic wounds remain elusive …

Mesenchymal stromal cells (MSCs) have well-characterized properties and thus represent
an attractive cell population for use in several therapeutic applications. Due to the limitations …

Colorectal cancer is the third most common cause of cancer‐associated deaths due to a
high recurrence rate and an increasing occurrence of resistance to established therapies …

Direct cell–cell contact between haematopoietic progenitor cells (HPCs) and their cellular
microenvironment is essential to maintain 'stemness'. In cancer biology, focal adhesion (FA) …

Mesenchymal stem cells (MSC) are increasingly being proposed as a therapeutic option for
treatment of a variety of different diseases in human and veterinary medicine. Stem cells …

The current gold standard for reconstructive bone surgery is based on autologous bone
grafts. However, the risk of complications at both the donor and recipient sites is …

Управление гомеостазом микроокружения костного мозга, где происходит гематопоэз,
осуществляется в результате взаимодействий двух действующих лиц: ГСК и …